| MARKER THERAPEUTICS INC. |
| USA |
| Gesundheit |
| US57055L2060 / A3D5YK |
| GX1 (Frankfurt) / MRKR (NASDAQ) |
| FRA:GX1, ETR:GX1, GX1:GR, NASDAQ:MRKR |
| - |
| https://markertherapeutic.. |
|
Marker Therapeutics, Inc., a clinical-stage immuno..
>Volltext.. |
| 18.05 Mio. EUR |
| 1.9 Mio. EUR |
| 4 Mio. EUR |
| -12.29 Mio. EUR |
| -12.19 Mio. EUR |
| -1.05 EUR |
| - |
| 16.15 Mio. EUR |
| -12.63 Mio. EUR |
| 5.66 |
| -12.99% |
| -48.42% |
| - |
| - |
| - |
| - |
| MARKER THERAPEUTICS, MARKER THERAPEUTIC |
| 17.12.25 |
|